Clinical Analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Wu, Dajun ^a,b   Zhu, Hong ^a   Tang, Hanjun ^b   Li, Changlin ^b   Xu, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

^b Chengdu 363 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; EARLY CANCER; ESOPHAGITIS; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HEMATOLOGIC DISEASE; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MALE; PNEUMONIA; RADIATION DOSE; RADIATION SICKNESS; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; RADIOSURGERY; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RADIOSURGERY; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960566100     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-84     Document Type: Article

References (30)

1. Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, Bosch WR, Michalski J, Galvin JM. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2009, 73:1235-1242. 10.1016/j.ijrobp.2008.11.019, 2911132, 19251095.
2. Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2006, 66:117-125. 10.1016/j.ijrobp.2006.04.013, 16765528.
3. Silvano G. New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC). Annals of Oncology 2006, 17.
4. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama 2010, 303:1070-1076. 10.1001/jama.2010.261, 2907644, 20233825.
5. Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Ciammella P, Franco P, Mantovani C, Borasio P, Scagliotti GV, Ragona R. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77. 10.1016/j.lungcan.2009.05.007, 19556022.
6. Shen Y, Zhang H, Wang J, Zhong R, Jiang X, Xu Q, Wang X, Bai S, Xu F. Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing control. Radiation Oncology 2010, 5.
7. Baba F, Shibamoto Y, Ogino H, Murata R, Sugie C, Iwata H, Otsuka S, Kosaki K, Nagai A, Murai T, Miyakawa A. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiation Oncology 2010, 5.
8. Bogart JA, Watson D, McClay EF, Evans L, Herndon JE, Laurie F, Seagren SL, Fitzgerald TJ, Vokes E, Green MR. Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235. Lung Cancer 2008, 62:92-98. 10.1016/j.lungcan.2008.02.006, 18367288.
9. Paumier A, Le Pechoux C. Radiotherapy in small-cell lung cancer: where should it go?. Lung Cancer 2010, 69:133-140. 10.1016/j.lungcan.2010.04.019, 20605651.
10. Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T. Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiation Oncology 2009, 4.
11. Ball D. Stereotactic radiotherapy for nonsmall cell lung cancer. Current Opinion in Pulmonary Medicine 2008, 14:297-302. 10.1097/MCP.0b013e328302405a, 18520262.
12. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2007, 2.
13. van der Voort van Zyp NC, Prevost JB, van der Holt B, Braat C, van Klaveren RJ, Pattynama PM, Levendag PC, Nuyttens JJ. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2010, 77:31-37. 10.1016/j.ijrobp.2009.04.080, 19864077.
14. Brown WT, Wu X, Amendola B, Perman M, Han H, Fayad F, Garcia S, Lewin A, Abitbol A, de la Zerda A, Schwade JG. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife. Cancer Journal 2007, 13:87-94.
15. Baba F, Shibamoto Y, Tomita N, Ikeya-Hashizume C, Oda K, Ayakawa S, Ogino H, Sugie C. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiation Oncology 2009, 4.
16. Cangir AK, Kutlay H, Akal M, Gungor A, Ozdemir N, Akay H. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter. [Erratum appears in Lung Cancer. 2005 Nov;50(2):281-2]. Lung Cancer 2004, 46:325-331. 10.1016/j.lungcan.2004.05.004, 15541817.
17. Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M, . Japanese National Chest Hospital Study G Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. 2005, Japanese National Chest Hospital Study G.
18. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009, 136:260-271. 10.1378/chest.08-0978, 19584208.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000, 92:205-216. 10.1093/jnci/92.3.205, 10655437.
20. Michaelson MD, Kaufman DS, Kantoff P, Oh WK, Smith MR. Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer 2006, 107:530-535. 10.1002/cncr.22043, 16804927.
21. Rassiah-Szegedi P, Salter BJ, Fuller CD, Blough M, Papanikolaou N, Fuss M. Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncologica 2006, 45:989-994. 10.1080/02841860600919225, 16982568.
22. Lax I, Panettieri V, Wennberg B, Amor Duch M, Naslund I, Baumann P, Gagliardi G. Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncologica 2006, 45:978-988. 10.1080/02841860600900050, 16982567.
23. Zhang P, Happersett L, Yang Y, Yamada Y, Mageras G, Hunt M. Optimization of collimator trajectory in volumetric modulated arc therapy: development and evaluation for paraspinal SBRT. International Journal of Radiation Oncology, Biology, Physics 2010, 77:591-599. 10.1016/j.ijrobp.2009.08.056, 20171809.
24. Hiraoka M, Matsuo Y, Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiotherapie 2007, 11:32-35.
25. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. International Journal of Radiation Oncology, Biology, Physics 2009, 75:677-682. 10.1016/j.ijrobp.2008.11.042, 19251380.
26. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiotherapy & Oncology 2010, 94:1-11. 10.1016/j.radonc.2009.12.008, 21780241.
27. Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. International Journal of Clinical Oncology 2004, 9:352-355. 10.1007/s10147-004-0435-z, 15549583.
28. Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 2007, 110:148-155. 10.1002/cncr.22763, 17516437.
29. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. International Journal of Radiation Oncology, Biology, Physics 2005, 63:1010-1015. 10.1016/j.ijrobp.2005.03.073, 16115740.
30. Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2010, 5:1091-1099.